Related Experiment Videos
Preliminary report: follow-up after dynamic cardiomyoplasty
A A Hagege1, M Desnos, J C Chachques
1Department of Cardiology, Boucicaut Hospital, Paris, France.
Lancet (London, England)
|May 12, 1990
Summary
Dynamic cardiomyoplasty improved heart function in some patients with heart failure, showing increased cardiac index and ejection fraction. Long-term benefits are possible, though risks like ventricular fibrillation exist.
Area of Science:
- Cardiology
- Biomedical Engineering
- Surgical Innovation
Background:
- Refractory heart failure poses significant challenges.
- Dynamic cardiomyoplasty is an investigational surgical approach.
- Evaluating long-term outcomes of dynamic cardiomyoplasty is crucial.
Purpose of the Study:
- To assess the hemodynamic and histological effects of dynamic cardiomyoplasty.
- To determine the long-term efficacy and safety of the procedure.
- To identify factors influencing patient outcomes after dynamic cardiomyoplasty.
Main Methods:
- Studied five patients 5-13 months post-dynamic cardiomyoplasty.
- Monitored hemodynamic parameters including cardiac index and ejection fraction.
- Performed histochemical analysis of stimulated muscle flaps.
Main Results:
- Two patients demonstrated significant increases in cardiac index (55%) and ejection fraction (75%).
- No patient experienced improvement in cardiac filling pressure.
- Histochemistry revealed predominantly type I (fatigue-resistant) muscle fibers without fibrosis.
- One patient with initial hemodynamic improvement died from ventricular fibrillation two years post-surgery.
Conclusions:
- Dynamic cardiomyoplasty can yield long-term hemodynamic benefits in selected heart failure patients.
- The procedure's success may be linked to muscle fiber type composition.
- Potential risks, such as fatal arrhythmias, warrant careful consideration.